|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CANADA LIFE OF AMERICA SERIES FUND INC, 497, 1998-02-19 |
Next: PINNACLE FINANCIAL SERVICES INC, SC 13G, 1998-02-19 |
<PAGE> 1
-----------------------------
OMB APPROVAL
-----------------------------
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response .... 14.90
-----------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2)*
EUROMED, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
- --------------------------------------------------------------------------------
(Title of Class of Securities)
298735101
-------------------------------------------------------
(CUSIP Number)
Gregory Alan Gaylor: 11440 West Bernardo Ct Ste 300
San Diego, CA 92127 (619)674-6669
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
February 12, 1998
-------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
Check the following box if a fee is being paid with the statement / /. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
SEC 1746(12-91)
<PAGE> 2
SCHEDULE 13D
CUSIP NO. 298735101 PAGE 2 OF 11 PAGES
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Gregory Alan Gaylor
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
N/A
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) / /
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES Gaylor: 126,500
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 373,123
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
503,723 shares for reporting group
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
39.45%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
2 of 11
<PAGE> 3
SCHEDULE 13D
CUSIP NO. 298735101 PAGE 3 OF 11 PAGES
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Jan Bouwman
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
No funds were used
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) / /
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
The Netherlands
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES Bouwman: 4,100
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 373,123
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
503,723 shares for reporting group
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
39.45%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
3 of 11
<PAGE> 4
Schedule 13D Amendment (2) EuroMed, Inc. Cusip 298735101
Respondents: Gregory Alan Gaylor Jan Bouwman
1. Security and Issuer:
Common Stock
EuroMed, Inc.
Wilhelminakanaal Noord 6
4902 VR Oosterhout
The Netherlands
2. Identity and Background:
(a) Gregory Alan Gaylor
(b) 11440 West Bernardo Court
Suite 300
San Diego, California 92127
(c) Investor
Maverick Advisors, Inc.
11440 West Bernardo Court
Suite 300
San Diego, California 92127
(d) No
(e) No
(f) USA
3. Source and Amount of Funds or Other Consideration:
No funds were used. Proxies were acquired under consent of
shareholder(s)
4. Purpose of Transaction:
The reporting individuals herein desire to replace the board of
directors of the issuer.
5. Interest in Securities of the Issuer:
(a) 503,723 aggregate shares for reporting group, 39.45% based
upon 1,277,000 total shares outstanding - such information as
disclosed by the issuer on December 8, 1997.
(b) 126,500 shares sole voting power; 373,123 shares shared
voting power, with Jan Bouwman
(c) Proxies were received for shares in aggregate of 101,175.
4
<PAGE> 5
Schedule 13D Amendment (2) EuroMed, Inc. Cusip 298735101
Respondents: Gregory Alan Gaylor Jan Bouwman
(d) Not applicable
(e) Not applicable
6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer:
Proxies for the issuer's common stock were acquired from the
following, with proxies in bold highlighted to designate those, which were
acquired subsequent to the previous 13DA filing:
<TABLE>
<S> <C>
Edwin Kissel MD, Hilda Ann Kissel JTWROS 42,200
Barbara Schiller 22,800
CIMO ASSET MANAGEMENT 26,100
Walter Schiller 20,000
Carol J. Piazza Trustee Piazza Family Trust 15,450
Vern Maynard FBO Maynard Family Trust 15,000
GOLDEN SHARE INVESTMENTS, LTD. 15,000
William C. Gaylor IRA 11,558
Saul Steinberg 10,000
DAVID RAPAPPORT 10,000
Frank Knight 8,000
C.D.J. Evers 6,500
Robert M. Mitchell 6,500
Jack Bob Wine FBO Jack Bob Wine Trust 6,000
Marc Voit 5,700
Gary A. Bartlett 5,400
MEI YU YANG CHIANG 5,000
John K. Waken + Gracie E. Waken Co TTEES FBO Waken Tr 5,000
Sal Federico 5,000
Randall M. Toig 5,000
Henry Miyatake 5,000
William G. Paton 5,000
Reb. Ephraim Chaim, Rochel Charitable Foundation 4,500
EDWARD J. ANDERSON 4,500
LAWRENCE SCHNEIDER TTEE SCHNEIDER FAMILY TRUST 4,000
CHENG HAN SHIAO 3,200
G. MARK TARPIN 3,000
Edward K. Binggeli 3,000
Espy P. Gregory 3,000
HSIU LING HSIAO 2,800
Russell Sargeant FBO Russell Sargeant Trust 2,300
Robert J. Vissa, Jr. 2,100
MILLENNIUM FINANCIAL GROUP, INC. 2,000
WILLIAM A. SCHWARTZ IRA 2,000
</TABLE>
5
<PAGE> 6
Schedule 13D Amendment (2) EuroMed, Inc. Cusip 298735101
Respondents: Gregory Alan Gaylor Jan Bouwman
<TABLE>
<S> <C>
MYUNG WOODS 2,000
CLARENCE T. YIM IRA 2,000
CLIFFORD D. KESTER TTE KESTER SURVIVOR'S TRUST 2,000
R.E. Keefe MD Tr FBO R.E. Keefe MD Trust 2,000
Raymond T. Stewart IRA 2,000
Wesley D. Mitchell 2,000
James Carroll Hill Trust, Adrian L. Hill Trustee 2,000
Adrian L. + Margaret J. Hill Trust, Adrian L., Margaret J. Hill TTEES 2,000
Ronald F. Anderson, Nykole Anderson JTWROS 2,000
R.E. Keefe Jr. Tr, Keefe Family Trust 2,000
Riad, Florence Abou-Mourad, JTWROS 2,000
Har Rose Farms 1,825
CAROL J. URIBE 1,750
Eileen S. Cassidy 1,631
Jacques Michel Vidal 1,600
Ingrid Kaempfert 1,600
Steve Coles 1,500
Carl B.O. Connor 1,500
Thomas J. Langan 1,500
Peter Stein, 1,464
Jean S. Crocco 1,400
VINCENT M. MOORE IRA 1,300
Stephen J. McArdle III, Susan Pleu, JTWROS 1,300
Ardis G. Avey Trust 1,125
Teague S. Crocco 1,100
DALE SINCLAIR 1,000
JOANNA M. GAUCHER 1,000
DONNA H. BLACKBURN 1,000
JOHN L. BLOOM 1,000
DON B. SCHIERLING FOR MATTHEW C. SCHIERLING 1,000
GEORGE TURNER 1,000
B.D. WATSON, JR. 1,000
Steven D., Carol A. Moore, JTWROS 1,000
Wing Mark 1,000
Townley L., Jane A. Anderson 1,000
Nancy L. Armstrong, Josephine Ulrech JT TEN 1,000
John R. Parks, III 1,000
Harvey N. Short Trustee, FBO Harvey N. Short Trust 1,000
James J., Karen L. Esper, TTEES Esper Family Nominee TR 1,000
Manuel Skip Molina 1,000
Barry Braune 1,000
Patrick Vesey, Jean Vesey JTWROS 1,000
FTC TR JB+R Graphic Services, Jasper W. Ormand 1,000
Lloyd L. Smith 1,000
</TABLE>
6
<PAGE> 7
Schedule 13D Amendment (2) EuroMed, Inc. Cusip 298735101
Respondents: Gregory Alan Gaylor Jan Bouwman
<TABLE>
<S> <C>
Eugene L. Nakamura 1,000
Philip M. Hanna, IRA 1,000
Julie I. Lane, IRA 1,000
Linda M. Wood, IRA 1,000
Harry E. Schorle, IRA 1,000
Carl Carlzen 1,000
Mavys Hendrix 910
Elaine McAninch 910
YEN HSU CHEN 900
William A. Carey, Jr. 775
ANTOINETTE BELINA 750
Ann, Warren Renfroe, JTWROS 700
NORA MEEHAN 600
Herman F. Zerweck 600
DR. SUBODH VATS, SHASHI VATS JT TEN 500
ROBERT C. PIKE, MARTHA A. PIKE 500
DAVID SILBERBERG 500
TIMOTHY A. GODSIN 500
E.W. HIBBARD 500
PEGGY BERGLAS 500
CHARLOTTE HINEY 500
WADE JACOBSEN 500
Gloria Luxenberg Trust 500
Frederick Weiner 500
Samuel B. Magids 500
DAVID BOUCHER 475
CARLO D/CAVALIERE, BARBARA A. CAVALIERE 400
TURNEY H. BRUNER 400
-------
Total Shares 373,123
=======
</TABLE>
7. Material to Be Filed as Exhibits:
No exhibits.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date: 2/16/98 /s/ GREGORY ALAN GAYLOR
Name/Title: Gregory Alan Gaylor
7
<PAGE> 8
Schedule 13D Amendment (2) EuroMed, Inc. Cusip 298735101
Respondents: Gregory Alan Gaylor Jan Bouwman
1. Security and Issuer:
Common Stock
EuroMed, Inc.
Wilhelminakanaal Noord 6
4902 VR Oosterhout
The Netherlands
2. Identity and Background:
(a) Jan Bouwman
(b) Boerenstraat 21
4201 GA Gorinchem
The Netherlands
(c) Financial Controller
Matrix Holding BV
Boerenstraat 21
4201 GA Gorinchem
The Netherlands
(d) No
(e) No
(f) The Netherlands
3. Source and Amount of Funds or Other Consideration:
No funds were used. Proxies were acquired under consent of
shareholder(s)
4. Purpose of Transaction:
The reporting individuals herein desire to replace the board of
directors of the issuer.
5. Interest in Securities of the Issuer:
(a) 503,723 aggregate shares for reporting group, 39.45% based
upon 1,277,000 total shares outstanding - such information as
disclosed by the issuer on December 8, 1997.
(b) 4100 shares sole voting power;
373,123 shares shared voting power, with Gregory Alan Gaylor
(c) Proxies were received for shares in aggregate of 101,175
8
<PAGE> 9
Schedule 13D Amendment (2) EuroMed, Inc. Cusip 298735101
Respondents: Gregory Alan Gaylor Jan Bouwman
(d) Not applicable
(e) Not applicable
6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer:
Proxies for the issuer's common stock were acquired from the
following, with proxies in bold highlighted to designate those, which were
acquired subsequent to the previous 13DA filing:
<TABLE>
<S> <C>
Edwin Kissel MD, Hilda Ann Kissel JTWROS 42,200
Barbara Schiller 22,800
CIMO ASSET MANAGEMENT 26,100
Walter Schiller 20,000
Carol J. Piazza Trustee Piazza Family Trust 15,450
Vern Maynard FBO Maynard Family Trust 15,000
GOLDEN SHARE INVESTMENTS, LTD. 15,000
William C. Gaylor IRA 11,558
Saul Steinberg 10,000
DAVID RAPAPPORT 10,000
Frank Knight 8,000
C.D.J. Evers 6,500
Robert M. Mitchell 6,500
Jack Bob Wine FBO Jack Bob Wine Trust 6,000
Marc Voit 5,700
Gary A. Bartlett 5,400
MEI YU YANG CHIANG 5,000
John K. Waken + Gracie E. Waken Co TTEES FBO Waken Tr 5,000
Sal Federico 5,000
Randall M. Toig 5,000
Henry Miyatake 5,000
William G. Paton 5,000
Reb. Ephraim Chaim, Rochel Charitable Foundation 4,500
EDWARD J. ANDERSON 4,500
LAWRENCE SCHNEIDER TTEE SCHNEIDER FAMILY TRUST 4,000
CHENG HAN SHIAO 3,200
G. MARK TARPIN 3,000
Edward K. Binggeli 3,000
Espy P. Gregory 3,000
HSIU LING HSIAO 2,800
Russell Sargeant FBO Russell Sargeant Trust 2,300
Robert J. Vissa, Jr. 2,100
MILLENNIUM FINANCIAL GROUP, INC. 2,000
WILLIAM A. SCHWARTZ IRA 2,000
</TABLE>
9
<PAGE> 10
Schedule 13D Amendment (2) EuroMed, Inc. Cusip 298735101
Respondents: Gregory Alan Gaylor Jan Bouwman
<TABLE>
<S> <C>
MYUNG WOODS 2,000
CLARENCE T. YIM IRA 2,000
CLIFFORD D. KESTER TTE KESTER SURVIVOR'S TRUST 2,000
R.E. Keefe MD Tr FBO R.E. Keefe MD Trust 2,000
Raymond T. Stewart IRA 2,000
Wesley D. Mitchell 2,000
James Carroll Hill Trust, Adrian L. Hill Trustee 2,000
Adrian L. + Margaret J. Hill Trust, Adrian L., Margaret J. Hill TTEES 2,000
Ronald F. Anderson, Nykole Anderson JTWROS 2,000
R.E. Keefe Jr. Tr, Keefe Family Trust 2,000
Riad, Florence Abou-Mourad, JTWROS 2,000
Har Rose Farms 1,825
CAROL J. URIBE 1,750
Eileen S. Cassidy 1,631
Jacques Michel Vidal 1,600
Ingrid Kaempfert 1,600
Steve Coles 1,500
Carl B.O. Connor 1,500
Thomas J. Langan 1,500
Peter Stein, 1,464
Jean S. Crocco 1,400
VINCENT M. MOORE IRA 1,300
Stephen J. McArdle III, Susan Pleu, JTWROS 1,300
Ardis G. Avey Trust 1,125
Teague S. Crocco 1,100
DALE SINCLAIR 1,000
JOANNA M. GAUCHER 1,000
DONNA H. BLACKBURN 1,000
JOHN L. BLOOM 1,000
DON B. SCHIERLING FOR MATTHEW C. SCHIERLING 1,000
GEORGE TURNER 1,000
B.D. WATSON, JR. 1,000
Steven D., Carol A. Moore, JTWROS 1,000
Wing Mark 1,000
Townley L., Jane A. Anderson 1,000
Nancy L. Armstrong, Josephine Ulrech JT TEN 1,000
John R. Parks, III 1,000
Harvey N. Short Trustee, FBO Harvey N. Short Trust 1,000
James J., Karen L. Esper, TTEES Esper Family Nominee TR 1,000
Manuel Skip Molina 1,000
Barry Braune 1,000
Patrick Vesey, Jean Vesey JTWROS 1,000
FTC TR JB+R Graphic Services, Jasper W. Ormand 1,000
Lloyd L. Smith 1,000
</TABLE>
10
<PAGE> 11
Schedule 13D Amendment (2) EuroMed, Inc. Cusip 298735101
Respondents: Gregory Alan Gaylor Jan Bouwman
<TABLE>
<S> <C>
Eugene L. Nakamura 1,000
Philip M. Hanna, IRA 1,000
Julie I. Lane, IRA 1,000
Linda M. Wood, IRA 1,000
Harry E. Schorle, IRA 1,000
Carl Carlzen 1,000
Mavys Hendrix 910
Elaine McAninch 910
YEN HSU CHEN 900
William A. Carey, Jr. 775
ANTOINETTE BELINA 750
Ann, Warren Renfroe, JTWROS 700
NORA MEEHAN 600
Herman F. Zerweck 600
DR. SUBODH VATS, SHASHI VATS JT TEN 500
ROBERT C. PIKE, MARTHA A. PIKE 500
DAVID SILBERBERG 500
TIMOTHY A. GODSIN 500
E.W. HIBBARD 500
PEGGY BERGLAS 500
CHARLOTTE HINEY 500
WADE JACOBSEN 500
Gloria Luxenberg Trust 500
Frederick Weiner 500
Samuel B. Magids 500
DAVID BOUCHER 475
CARLO D/CAVALIERE, BARBARA A. CAVALIERE 400
TURNEY H. BRUNER 400
-------
Total Shares 373,123
=======
</TABLE>
7. Material to Be Filed as Exhibits:
No exhibits.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date: 2/16/98 /s/ JAN BOUWMAN
Name/Title: Jan Bouwman
11
|
|